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& INDICATIONS
Approximately 60% of transplants in children are
indicated for biliary atresia. Other conditions include virus-
or drug-related fulminant hepatitis, biliary hypoplasia,
alpha-1 antitrypsin deficiency, tyrosinemia, Wilson’s dis-
ease, primary sclerosing cholangitis, and autoimmune
hepatitis (1).
Until July 2006, the transplant waiting list in Brazil was
organized in chronological order, i.e., the first person on the
list was the person who had registered first. Currently, the
list is sorted by severity, i.e., all candidates are given a score
(Pediatric End-Stage Liver Disease [PELD] for children and
Model for End-Stage Liver Disease [MELD] for adults) that
takes into account serum albumin levels, prothrombin time,
bilirubin levels, and other data. The first person on the list is
now therefore the one who is in the most critical situation
(i.e., has the highest score).
& DONOR
The acceptance of a potential donor requires the follow-
ing: ABO compatibility, normal or only slightly altered liver
function tests, and hemodynamic stability. Because the
transplant waiting list is a single regional list, most donors
for children are adults.
When an adult liver is transplanted to a child, it is
necessary to reduce the liver size by transplanting only the
left lobe. When the discrepancy between the weights of the
donor and recipient is very large (or when a living donor
transplant is used), only the left lateral segment is used.
When a brain-dead donor is in a stable hemodynamic
condition and has normal liver function tests, it is possible
to use the left lateral segment for a child and the right lobe
for an adult recipient (this case is called split liver).
& RECIPIENT’S SURGERY
Hepatectomy of the recipient is usually difficult due to
portal hypertension, previous portoenterostomy, intestinal
adhesions, and coagulation disorders. To remove the
diseased liver, it is necessary to clamp the inferior vena
cava in the supra- and infrahepatic region and the hilar
structures. When the whole liver or the left lobe is used, the
retrohepatic inferior vena cava of the donor is transplanted
along with the graft. The process begins with anastomosis of
the suprahepatic vena cava followed by the infrahepatic
vena cava. In left lateral segment transplants, the left
suprahepatic inferior vena cava of the recipient is anasto-
mosed. The portal vein and hepatic artery are then
reconstructed, and finally, the biliary tract is restored by
Roux-en-Y biliary-digestive anastomosis (Figure 1).
In children with liver cirrhosis and established collateral
circulation, total clamping of the inferior vena cava causes a
decrease in blood pressure that is usually easily manageable
by volume administration. However, children with acute
liver failure do not present with collateral circulation, and
there may be greater hemodynamic repercussions due to
blockage of the vena cava. In such cases, one alternative is to
perform only a partial clamping of the inferior vena cava for
end-to-side anastomosis with the hepatic vein of the graft
(Figures 2 and 3).
& POSTOPERATIVE CARE
Neurological concerns
The initial neurological evaluation is difficult due to the
influence of anesthetic drugs, the metabolism of which is
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altered by abnormal liver function and possible abnormal
kidney function. The level of consciousness is an accurate
parameter for assessing the function of the newly trans-
planted liver; therefore, it is imperative that drugs with
sedative effects, especially benzodiazepines (which undergo
hepatic metabolism), be avoided during the early post-
operative period.
Seizures may occur in up to 30% of children following
liver transplantation (2,3). Hypoglycemia, electrolyte dis-
turbances (including hypomagnesemia), and very high
serum levels of immunosuppressive drugs, such as cyclos-
porine or tacrolimus, are among the causes of seizures. Any
generalized tonic-clonic seizures of unknown cause and all
focal seizures should indicate the use of cranial computed
tomography to evaluate the possibility of central nervous
system bleeding.
A nonfunctional primary graft causes cerebral edema and
increased intracranial pressure, often requiring an intracra-
nial pressure monitor to better manage and maintain
cerebral perfusion pressure.
Respiratory concerns
Almost all patients arrive at the ICU with an endotracheal
tube, although extubation of stable patients is usually
possible within 48 hours. The need for longer ventilatory
support may be associated with increased respiratory
demand due to pulmonary edema, pleural effusion, atelec-
tasis, increased carbon dioxide production, or airway
infection or obstruction. In addition, decreased ventilatory
capacity due to respiratory depression caused by excessive
sedation, liver dysfunction, malnutrition, or metabolic
disorders may also be associated with the need for longer
ventilatory support.
Fluid overload causes pulmonary edema and pleural
effusion, typically on the right side. This effusion involves
ascitic fluid that is displaced through the right diaphragm,
which can be injured during surgery due to the negative
pressure in the pleural cavity. Treatment consists of the use
of diuretics and volume restriction because the effusion is
self-limited and does not require drainage. A chest tube may
be inserted to drain the liquid and allow lung expan-
sion, but this is only done in cases involving respiratory
compromise.
In some cases, the effusion starts to form again after a
month, leading to ventilatory restriction that requires
punctures (sometimes repeatedly). Recurring effusion is
usually associated with hepatomegaly and ascites and can
occur concurrently with suprahepatic anastomotic stenosis
(a condition similar to Budd-Chiari syndrome) (4).
Electrolyte disturbances, such as hypophosphatemia,
hypocalcemia, hypomagnesemia, and hypokalemia, may
lead to respiratory muscle dysfunction and difficulty in
extubation.
Lung atelectases are important causes of respiratory
distress, especially in very young children with ascites
and abdominal distension. Attempts to wean chronically
undernourished individuals from ventilation before feeding
are useless and harmful because they merely lead to
increased energy consumption and fatigue.
Finally, both pulmonary and systemic infections are a
frequent cause of respiratory dysfunction in the early
postoperative period after liver transplantation.
Cardiovascular concerns
All patients should continue to receive electrocardio-
graphic monitoring and be monitored with invasive and
noninvasive blood pressure-measuring devices and central
venous pressure-measuring devices.
Over 70% of patients present with hypertension, which
often requires drug-based treatment (5). The cause of this
Figure 1 - Surgery scheme for whole liver transplantation.
Vascular anastomoses are shown.
Figure 2 - View of the end-to-side anastomosis between the
hepatic vein of the graft and the inferior vena cava. The inferior
vena cava is partially clamped.
Figure 3 - Final view of the liver graft after implantation (living
donor transplantation, left lateral segment).
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hypertension is multifactorial, involving volume overload,
elevated renin levels, and the use of steroids and calcineurin
inhibitors. Hypertension is particularly dangerous due to its
frequent association with coagulopathy and thrombocyto-
penia. In addition to the use of diuretics, the use of sodium
nitroprusside is frequent in the first days after surgery, and
oral medications, such as amlodipine and eventually
angiotensin-converting enzyme inhibitors, are gradually
introduced.
The presence of hypotension is associated with liver
dysfunction, abdominal bleeding, and systemic infections.
Finally, approximately 30% of patients may have episodes
of bradycardia of unknown cause, without any hemody-
namic repercussions (6).
Fluids and electrolytes
Patients usually experience hypervolemia after surgery,
and the intravascular compartment can be expanded,
normal, or reduced in volume. Heart rate, central venous
pressure, arterial pressure, and urine output should be
monitored to calculate the initial water requirement, which
is usually restricted to 60-80% of baseline maintenance.
Dilutional hyponatremia is commonly observed, with
increased total body sodium; therefore, this electrolyte
should not be added to the maintenance fluid. Due to cell
lysis in the transplanted organ during the ischemia-
reperfusion process, there is a tendency toward hyperkale-
mia; thus, potassium should also not be added to the fluid.
Commonly, there is a need for a packed red blood cell
transfusion during the intraoperative period; the citrate
anion present in stored blood chelates the calcium ion,
resulting in a tendency toward hypocalcemia in the
immediate postoperative period.
Hypoglycemia occurs in graft dysfunction; however,
there is a tendency toward hyperglycemia when the liver
is functioning well due to the stress caused by the surgical
procedure and the use of corticosteroids. A 5% glucose
solution is therefore initially used, with periodic monitoring
of blood glucose levels.
Gastrointestinal concerns
After transplantation, there is risk of ulceration of the
stomach and duodenum due to stress and steroid therapy.
All patients should therefore receive gastric acid secretion
blockers.
When gastrointestinal bleeding is present, coagulation
abnormalities should be assessed, and anticoagulants and
antiplatelet drugs may be discontinued. Upper gastrointest-
inal endoscopy is an important resource for the diagnosis
and treatment of gastrointestinal bleeding in most cases.
When bleeding esophageal varices are present or when the
source of bleeding is not diagnosed by endoscopy,
emergency Doppler ultrasound of the abdomen is required
because this bleeding can be a manifestation of portal vein
thrombosis.
As noted, most of the indications for liver transplantation
in children involve biliary atresia with previous portoenter-
ostomy. Thus, during the recipient’s surgery, it is necessary
to release large numbers of adhesions between the bowel
loops and liver. It is not uncommon for accidental
perforation of these loops or seromuscular injuries to go
unnoticed. The early postoperative immunosuppression
state of the transplant hinders the healing process and masks
the signs and symptoms of perforated acute abdomen.
Abdominal reexploration is indicated whenever there is
any doubt regarding abdominal pain, increased nasogastric
tube output, or prolonged ileus.
Treatment of the liver graft
Ischemia-reperfusion leads to characteristic injuries in the
newly transplanted liver that are known as preserva-
tion injuries. The histology of the post-reperfusion biopsy
reveals neutrophilic infiltrate in the sinusoids and hepato-
cyte apoptosis. The progression of this injury is evidenced
by cell ballooning and cholestasis (7). Preservation injury,
which is present to some degree in all cases, produces a
characteristic enzymatic curve in which there is a linear
increase in serum hepatocyte enzymes starting from the first
postoperative day and then a decrease from the fourth to
fifth day. The levels of canalicular enzymes (particularly
gamma-glutamyl transpeptidase or GGT) increase more
gradually and slowly decline from the seventh to the tenth
postoperative day.
Primary graft dysfunction is the most common cause of
early graft loss and is characterized by acute liver failure
(e.g., encephalopathy, coagulopathy, and hemodynamic
instability), significant elevation in serum liver enzymes
(AST/ALT above 2,500 IU/L), and multiple organ failure
(kidney failure and pulmonary complications).
The cause of primary graft dysfunction is the irreversible
loss of hepatocyte function due to ischemia-reperfusion
injury. The risk factors include a donor age greater than 50
years, macrosteatosis (greater than 30% of hepatocytes),
severe donor hypernatremia (greater than 170 mEq/L), and
prolonged cold ischemia time (over 18 hours) (8).
There is no effective treatment for primary graft dysfunc-
tion, and patient survival depends on early retransplantation.
Vascular occlusions
Hepatic artery thrombosis. Thrombosis of the hepatic
artery is the most common vascular occlusion, especially for
living donor transplants, in which anastomosis is performed
between smaller arteries (8). It is a catastrophic complication
and may present as acute liver failure, biliary fistula,
intermittent fever, or asymptomatic elevation of enzymes.
Hepatic artery thrombosis and biliary complications are
correlated because irrigation of the biliary tract is exclusively
arterial.
Arterial thrombosis in recipients of cadaveric grafts
typically manifests in the first two weeks as fulminant
hepatic necrosis with rapid clinical deterioration. Large
increases in hepatocyte enzymes and worsening of ence-
phalopathy and coagulation are observed. Late occlusions
may be asymptomatic and may involve the formation of
collaterals that supply the liver.
Diagnosis is made based on the absence of flow in
Doppler ultrasound, which is performed daily during the
first week after transplantation, with sensitivity rates that
reach 100% depending on the experience of the examiner.
Emergency surgical reexploration and thrombectomy may
be indicated in cases of early occlusions (9). In most patients,
thrombosis recurs, indicating the need for retransplantation.
A peculiar and interesting aspect of living donor transplants
is that within the first few days after surgery, hepatic artery
thrombosis progresses silently without clinical or laboratory
manifestations, and a diagnosis may only be performed by
ultrasound examination.
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Antiplatelet agents are used for the prophylaxis of arterial
thrombosis. When the International Normalized Ratio (INR)
levels are less than or equal to 3.0, intravenous heparin
infusion is initiated at a dose of 100 U/kg/day, which is
maintained for 15 days.
Portal vein thrombosis. This condition is less frequent
than hepatic artery thrombosis. It manifests as liver failure (in
early thrombosis), complications of portal hypertension, such
as variceal bleeding and encephalopathy, or an asymptomatic
elevation in enzymes. Diagnosis is performed by Doppler
ultrasound, and a positive diagnosis indicates the need for a
new surgery during early thrombosis; the success rate of this
approach is satisfactory. Late cases are usually asymptomatic
or present as portal hypertension, which tends to be
compensated for over time.
Obstruction of the hepatic veins. In cases of transplantation
of the left lateral segment (end-to-side anastomosis of the
left hepatic vein in the cava of the recipient), the hepatic
vein may be obstructed (4,11). Thrombosis itself is rare, and
stenosis is most frequently observed in this anastomosis
starting at one month after transplantation. Obstruction of
the hepatic vein presents as hepatomegaly and ascites,
which is sometimes responsible for the formation of a high-
volume pleural effusion that leads to respiratory failure.
Doppler ultrasound can detect large increases in blood
flow velocity in the region of the anastomosis; thus,
cavography is indicated. Interventional radiology can dilate
the region of stenosis or a stent can be fitted, with
immediate relief of symptoms (4,11).
Biliodigestive anastomotic dehiscence. Biliary complications
typically occur after the fifth postoperative day. Biliary fistula
manifests as fever, pain in the right upper quadrant, and
discharge of bilious liquid through the abdominal drains.
Leukocytosis, increased canalicular enzyme levels, and
eventual fluid collection that can be detected on ultrasound
may occur. New surgical procedures are required for
effective drainage of the fluid collection and detection of
the fistula site. If the leak originates from the raw liver surface
in cases of partial transplants, drainage of the fluid collec-
tion is sufficient. In cases of biliodigestive anastomotic
dehiscence, a new anastomosis with adequate drainage
should be performed.
In late fistulas of the raw surface and fistulas that are
difficult to close, the possibility of stenosis of the biliodi-
gestive anastomosis must be considered. Stenosis can also
manifest as increased canalicular enzyme levels; in this case,
a liver biopsy reveals canalicular biliary proliferation
(Figure 4).
Most stenoses can be treated with dilation by percuta-
neous transhepatic cholangiography, wherein a bile drain is
placed to shape the anastomosis for approximately six
months. When percutaneous treatment is not possible, a
new surgery is indicated.
Immunosuppression
Immediately after graft reperfusion, 20 mg/kg of methyl-
prednisolone is administered; on the following day, 5 mg/
kg is divided into four doses. Thereafter, the dose is
decreased on a daily basis to 5 mg and is replaced by
5 mg of prednisone (or a half dose in young children),
which is maintained for at least one year.
In addition to the corticosteroid, the immunosuppressive
drug of choice is currently tacrolimus (FK 506), a calcineurin
inhibitor that inhibits the action of interleukin-2, which
activates T lymphocytes, a central component in transplant
rejection. Tacrolimus is a potentially nephrotoxic drug and
can cause vomiting, central nervous system disorders, and
hypertension when administered at very high levels. In
cases of late renal injury caused by calcineurin inhibitors,
the doses of these immunosuppressant agents may be
reduced by combining them with other drugs with similar
effects and less renal toxicity, such as mycophenolate and
sirolimus (10).
Hematological care
Intra-abdominal bleeding may occur in the first few days
after surgery; thus, periodic monitoring of the serum
hemoglobin level and abdominal drain output is important.
The intensity of bleeding is usually greater in reduced-size
liver transplants due to the presence of the raw surface of
the graft.
A relatively common scenario known as retained clot
syndrome occurs during the early postoperative period.
After the initial gradual improvement in coagulation,
platelet count, and decreased blood drainage, there is a
significant increase in intracavitary bleeding, thrombocyto-
penia, and coagulopathy, which do not revert despite the
administration of blood products. With the improvement of
liver function, the collected blood in the abdominal cavity
forms large clots due to slow and diffuse hemorrhaging.
These clots are responsible for the local consumption of
platelets and coagulation factors, thus perpetuating the
bleeding. Laparotomy is therefore necessary to clean the
cavity and remove the clots, with possible hemostasis of
some of the active bleeding.
& INFECTIOUS DISEASES
Infectious diseases are very common because patients
are generally in a very compromised condition, may be
malnourished, are likely to have multiple points of entry for
microorganisms (e.g., incisions, catheters, probes), and are
commonly using immunosuppressive drugs.
In the first weeks after transplantation, bacteria are the
main infectious agents, the most common of which include
Figure 4 - Histology of the liver graft illustrating canalicular
biliary proliferation. Note the proliferated ducts in the periphery
of the portal space.
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enterococci and gram-negative bacteria in the abdomen.
Thus, many centers prophylactically use a combination of
ampicillin and cefotaxime in the perioperative period. Signs
of infection in children who have undergone transplantation
can vary from laboratory abnormalities without clinical
symptoms (such as leukocytosis or leukopenia; hyponatre-
mia; and elevated serum, liver, and urea enzymes) to
irreversible fulminant septic shock. The presence of fever
may indicate culture collection and investigation of the
focus of infection, and it is important to immediately
administer either specific or broad-spectrum antibiotics,
depending on whether the agent can be identified.
Fungal infections are also relatively frequent, with
Candida albicans being the most common infectious agent.
Risk factors are prolonged antibiotic therapy, the presence
of vascular complications, intestinal perforations, the need
for endotracheal reintubation, steroid therapy, and retrans-
plantation. Disseminated disease is the most common
presentation. Thus, fluconazole may be prophylactically
administered during the first weeks after transplantation.
Viral infections usually occur during the first month, with
Cytomegalovirus being the most common infectious agent.
& REJECTION
Acute cellular rejection is very common and can occur in
70% of cases (7). The peak incidence occurs between the fifth
and tenth postoperative day and can manifest with
nonspecific symptoms such as mild fever and abdominal
pain. There is a predominant increase in canalicular
enzymes (e.g., GGT) because the inflammatory process
occurs through a lymphocytic infiltrate in the portal space
with duct and endothelial insult of the portal branches.
Hepatocytes are destroyed only in severe cases. The
diagnosis must be confirmed by biopsy. After confirmation,
treatment is introduced, which consists of pulse corticoster-
oids (methylprednisolone 20 mg/kg once a day for three
days) and adjustment of the immunosuppressive drugs,
with resolution occurring in most cases.
Chronic rejection usually appears after the first month
of transplantation, presenting as progressive jaundice
and itching, sometimes accompanied by acholic stools.
Canalicular enzyme levels are increased, and diagnosis is
confirmed by a liver biopsy showing the disappearance of
bile ducts in the portal space. The prognosis is poor, and
treatment consists of increasing levels of immunosuppres-
sants and eventual retransplantation.
& RELAPSE OF PRIMARY DISEASE
In autoimmune diseases, such as autoimmune hepatitis
and primary sclerosing cholangitis, relapse may occur in the
graft, and maintenance with higher levels of corticosteroids
is required to prevent this process from occurring.
In cases in which adequate prophylaxis is not adminis-
tered, viral hepatitis B and C recur with great frequency in
the transplanted liver. For hepatitis B virus, anti-HBV
immunoglobulin and nucleoside analogues (lamivudine)
may be administered. Interferon and ribavirin may be used
to prevent the recurrence of hepatitis C virus.
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